During the past decade, Northwestern Medical Group conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 7 clinical trials were completed, i.e. on average, 41.2% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 7 clinical trials were completed. i.e. 116.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northwestern Medical Group" #1 sponsor was "Pfizer" with 7 trials, followed by "AstraZeneca" with 3 trials sponsored, "Madrigal Pharmaceuticals, Inc." with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Gilead Sciences" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwestern Medical Group" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "Foundation for Female Health Awareness" with 1 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator and "Omron Healthcare Co., Ltd." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Northwestern Medical Group" are "Alopecia Areata" (2 trials), "Diabetes Mellitus, Non-Insulin-Dependent" (2 trials), "Non-Alcoholic Fatty Liver Disease" (2 trials), "Transthyretin (TTR) Amyloid Cardiomyopathy" (2 trials) and "Brain Neoplasms" (1 trials). Many other conditions were trialed in "Northwestern Medical Group" in a lesser frequency.

Most popular intervention types in "Northwestern Medical Group" are "Drug" (19 trials), "Biological" (1 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "AC2993" (3 trials), "Resmetirom" (2 trials), "Tafamidis" (2 trials) and "BI 1467335" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northwestern Medical Group" are 20 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Northwestern Medical Group". undefined are not yet recruiting, 3 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Northwestern Medical Group, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Northwestern Medical Group, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".